Tisotumab Vedotin: The First FDA-Approved Antibody-Drug Conjugate for Cervical Cancer.
作者信息
De Surya K
机构信息
Conju-probe, San Diego, CA, USA.
出版信息
Anticancer Agents Med Chem. 2022 Aug 4;22(16):2808-2810. doi: 10.2174/1871520622666220421095240.
Abstract
摘要
Zotero 插件